332 related articles for article (PubMed ID: 7688738)
1. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
Okada M; Howell BW; Broome MA; Cooper JA
J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
[TBL] [Abstract][Full Text] [Related]
2. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.
Murphy SM; Bergman M; Morgan DO
Mol Cell Biol; 1993 Sep; 13(9):5290-300. PubMed ID: 7689149
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
[TBL] [Abstract][Full Text] [Related]
4. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.
Neet K; Hunter T
Mol Cell Biol; 1995 Sep; 15(9):4908-20. PubMed ID: 7544435
[TBL] [Abstract][Full Text] [Related]
5. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.
Weng Z; Thomas SM; Rickles RJ; Taylor JA; Brauer AW; Seidel-Dugan C; Michael WM; Dreyfuss G; Brugge JS
Mol Cell Biol; 1994 Jul; 14(7):4509-21. PubMed ID: 7516469
[TBL] [Abstract][Full Text] [Related]
6. Csk suppression of Src involves movement of Csk to sites of Src activity.
Howell BW; Cooper JA
Mol Cell Biol; 1994 Aug; 14(8):5402-11. PubMed ID: 7518562
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.
Hirai H; Varmus HE
Mol Cell Biol; 1990 Apr; 10(4):1307-18. PubMed ID: 2108315
[TBL] [Abstract][Full Text] [Related]
8. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.
Seidel-Dugan C; Meyer BE; Thomas SM; Brugge JS
Mol Cell Biol; 1992 Apr; 12(4):1835-45. PubMed ID: 1549129
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.
Bjorge JD; Bellagamba C; Cheng HC; Tanaka A; Wang JH; Fujita DJ
J Biol Chem; 1995 Oct; 270(41):24222-8. PubMed ID: 7592628
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer BJ; Baltimore D
Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
[TBL] [Abstract][Full Text] [Related]
12. p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells.
Okamura H; Resh MD
J Biol Chem; 1995 Nov; 270(44):26613-8. PubMed ID: 7592885
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
14. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions.
Erpel T; Superti-Furga G; Courtneidge SA
EMBO J; 1995 Mar; 14(5):963-75. PubMed ID: 7534229
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
17. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
18. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
19. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
Roussel RR; Brodeur SR; Shalloway D; Laudano AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
[TBL] [Abstract][Full Text] [Related]
20. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
Garcia P; Shoelson SE; Drew JS; Miller WT
J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
